Enzychem Lifesciences

Enzychem Lifesciences is a company listed under the stock ticker 183490 (KR).

View the org chart displaying its 2 main executives

Most searched biographies at Enzychem Lifesciences

• Ki Young Sohn, Chief Executive Officer and Chairman of the Board
• Hye-Kyung Kim, Vice Chairman of the Board

Create your alert
to follow the executive moves at Enzychem Lifesciences.

Enzychem Lifesciences has 2,288 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology

• Attovia Therapeutics has just announced a $150 Million fundraising (posted on May 14 2024).
• Bruker has announced the acquisition of NanoString Technologies  (posted on May 13 2024).
• Aardvark Therapeutics has just announced a $85 Million fundraising (posted on May 12 2024).

Popular contacts in Biotechnology

• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics
• Carl Gordon - Director at Adicet Bio
• Vik Bajaj - Director at Interline Therapeutics

Learn more about the Biotechnology industry >

Press releases by Enzychem Lifesciences

Social media about Enzychem Lifesciences

• Enzychem Lifesciences on Wikipedia, Google News & Yahoo Finance
• Enzychem Lifesciences on LinkedIn, Twitter & YouTube

Call Enzychem Lifesciences at +82 ...

View the org chart

Register to receive your alert

Report an error